These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 9375940)
1. Future horizons in cardiovascular molecular therapeutics. Dzau VJ; Gibbons GH; Mann M; Braun-Dullaeus R Am J Cardiol; 1997 Nov; 80(9A):33I-39I. PubMed ID: 9375940 [TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ; Bourgeois M; Harbison RD Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [TBL] [Abstract][Full Text] [Related]
3. Future perspectives and potential implications of cardiac myocyte apoptosis. Haunstetter A; Izumo S Cardiovasc Res; 2000 Feb; 45(3):795-801. PubMed ID: 10728403 [TBL] [Abstract][Full Text] [Related]
4. [Gene therapy in heart diseases]. Tanner FC; Largiadèr T; Yang Z; Lüscher TF Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders. Spieker LE; Noll G; Lüscher TF Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028 [TBL] [Abstract][Full Text] [Related]
6. The endothelium in health and in cardiovascular disease. Garćia-Palmieri MR P R Health Sci J; 1997 Jun; 16(2):136-41. PubMed ID: 9285990 [TBL] [Abstract][Full Text] [Related]
7. Role of magnesium in cardiovascular diseases. Kolte D; Vijayaraghavan K; Khera S; Sica DA; Frishman WH Cardiol Rev; 2014; 22(4):182-92. PubMed ID: 24896250 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction: implications for therapy of cardiovascular diseases. Bell DM; Johns TE; Lopez LM Ann Pharmacother; 1998 Apr; 32(4):459-70. PubMed ID: 9562142 [TBL] [Abstract][Full Text] [Related]
9. Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum. Custodis F; Reil JC; Laufs U; Böhm M J Cardiol; 2013 Sep; 62(3):183-7. PubMed ID: 23806547 [TBL] [Abstract][Full Text] [Related]
10. Molecular advances in cardiac and cardiovascular disease. Basile-Borgia A; Abel JH; Mahloogi H Perfusion; 1999 Mar; 14(2):89-99. PubMed ID: 10338320 [TBL] [Abstract][Full Text] [Related]
11. Perspective: cardiovascular disease in the postgenomic era--lessons learned and challenges ahead. Epstein JA; Rader DJ; Parmacek MS Endocrinology; 2002 Jun; 143(6):2045-50. PubMed ID: 12021168 [TBL] [Abstract][Full Text] [Related]
13. Reprogramming the cell cycle machinery to treat cardiovascular disease. Bicknell KA; Brooks G Curr Opin Pharmacol; 2008 Apr; 8(2):193-201. PubMed ID: 18243794 [TBL] [Abstract][Full Text] [Related]
14. Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases? Bellien J; Joannides R; Richard V; Thuillez C Pharmacol Ther; 2011 Jul; 131(1):1-17. PubMed ID: 21514320 [TBL] [Abstract][Full Text] [Related]
15. Current indications for ACE inhibitors and HOPE for the future. Burch S; Ou N Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599 [TBL] [Abstract][Full Text] [Related]
16. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Houston MC Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494 [TBL] [Abstract][Full Text] [Related]
17. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine. Shimokawa H; Satoh K Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233 [TBL] [Abstract][Full Text] [Related]
18. Targeting the cell cycle machinery for the treatment of cardiovascular disease. Bicknell KA; Surry EL; Brooks G J Pharm Pharmacol; 2003 May; 55(5):571-91. PubMed ID: 12831500 [TBL] [Abstract][Full Text] [Related]
19. Role of hypertension in atherosclerosis and cardiovascular disease. Hollander W Am J Cardiol; 1976 Nov; 38(6):786-800. PubMed ID: 136891 [TBL] [Abstract][Full Text] [Related]
20. Beneficial actions of nitrates in cardiovascular disease. Abrams J Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]